Dengue fever which spreads through mosquitoes is one of the viral infections that has become a serious health concern mostly in the recent past particularly in tropical and subtropical regions. The Dengue fever is caused by the Dengue virus (DENV) which is mostly spread through aegypti mosquitos as well as albopictus. Dengue come in four DENV variants- DENV-1, DENV-2, DENV-3 and DENV-4 and depending on its prior exposure to the patient virus it can prove to be of varying degree of threat.
Rising Tide of Dengue Incidence Across The Globe
Case in point, the number of reported dengue fever cases has shocked the public due to the rapid increment to a level which seems unhealthy. The world health organization had indicated, that by I August 20244, the levels of dengue cool ring had reached over 123 million cases. This was almost two times the cases reported the previous year. Countries especially in South East Asia, Americas and Africa has basically suffered more on this concerning trend whereby changes in the environment due to urbanization and the increase of travel around the world has added to the causes of the disease.
The rise of the cases and many emergencies recalls in the standing regions has led the WHO to declare the red alert (Grade 3) concerns brief rather than respond to the outbreak setting up the order and control over the appropriate preventive systems for the patients and enhance the clinical management and surveillance of conventional cases.
Without immediate deployment of more strong control measures, the menace is supposed to involve five billion people by the year 2050.
Symptoms and Complaints of some diseases
Dengue usually develops as a flu type with symptoms including a sudden onset of fever, a severe headache, pain behind the eyes, as well as muscular, and joint pain, nausea, vomiting and rashes. However, while most cases are a mild, some can manifest as severe dengue, also referred to as Dengue Hemorrhagic Fever (DHF) or Dengue Shock Syndrome (DSS programs), and may lead to organ failure and death. Severe dengue occurs especially in patients that have been infected with a different serotype of the virus at the earlier time.
Strategies for Prevention and Control
As there is no specific antiviral treatment for Dengue, it is essential to control the mosquito populations to prevent this disease from spreading as the key principle of Prevention. Vector control measures mainly include removal of stagnant collections of water to limit mosquito breeding, application of pesticides, and encouraging the use of deodorants and insect nets.
One vaccine that is called Dengvaxia has also been made and is in use in some population groups but its success in controlling the disease is dependent on previous infection with the virus. Global organizations such as WHO are still funding research and the making of vaccines to combat this disease that on the rise.
Dengue Mitigation Efforts: Get Up and Do Something
Control strategies in the case of dengue are centered on the characteristics of the Aedes mosquitoes and how effective they can be Modified. These mosquitoes prefer urban settings for breeding and tend to deposit eggs in small water-filled cavities available in virtually all homes. Such changes in climate have also increased the geographical areas in which these mosquitoes can inhabit and spread dengue where it was not prior.
Nonetheless, the details regarding the public health systems in particular regions most affected by dengue don’t help in it either. In some countries, especially in Africa, bearing many health complications and addressing many outbreaks, cuts short the management of the. outbreak( CDC Emergency Preparedness ) (World Health Organization (WHO).
The Global Fight Against Dengue: How it Works and What Are the Barriers
One of the newly emerging and most globalized viral diseases in the world is Dengue fever, which has increased sharply as a result of issues such as urbanization and climate change to name a few. As a reaction to this rise, governments, international health organizations and research organizations are stepping up their war against the disease. These efforts include but are not limited to improving surveillance, vector control, and development of vaccines and international cooperation.
Dengue surveillance and response systems
One of the most fundamental elements of the global struggle against dengue is the strengthening of their surveillance systems. The World Health Organization (WHO) has developed the Global Strategic Preparedness, Readiness, and Response Plan for Dengue, as well as being extended to other Aedes-borne arboviruses such as Zika and chikungunya. In that plan, emphasis is placed on providing prompt as well as real time surveillance of possible outbreaks to prevent transmission outside the affected countries.
World Health Organization (WHO). Countries are also urged to enhance cross border and out of the region particularly southeast regions information provision about data on recorded cases of dengue which is endemic to southeast Asia, as well as the Americas and Africa.
Vector Control Attempts
Owing to the fact that dengue is transmitted mainly by Aedes aegypti mosquitoes, vector control continues to be the most important means of prevention. WHO and other governments are working towards the minimization of the mosquito breeding sites through engaging the communities. More efforts, like moving from house to house to emphasize the disposal of stagnant water where the mosquitoes hatch should be important
World Health Organization(WHO)
Apart from these traditional forms of control, more effective means are being used. One promising strategy is the use of sterilised mosquitoes that do not carry dengue. However, transduction of Aedes mosquitoes with Wolbachia is a cheaper and easier approach to make them dengue proof. This method has been encouraging as in controlling transmission in Brazil and Indonesian provinces.
The Vaccine Development
Considering the fact that controlling the transmission of dengue involves vector control, it is the ultimate goal of containing this menace as it is a sustainable control measure. Still, the most reliable solution remains the pursuit and development of an effective dengue vaccine. So far, the most noteworthy vaccine Dengvaxia has only been recommended for people aged 9-45 and has undergone previous dengue virus infection. However, it also has some limitations hence its cautious deployment especially in children with no prior dengue infection.
Nevertheless, there is active development of second-generation vaccines, which are intended to be less toxic and more efficacious in a wider population, considering the restraints.
International Cooperation and Funding
International collaboration is also important in the fight against dengue at a global level. WHO, PAHO, and the Global Fund, among others, are mobilizing resources to support the countries’ response to the impact of diseases. WHO’s evaluation of the current situation of dengue worldwide and elevation of the grade to that of an emergency level 3 – the highest – has opened doors for respective nations to militarize resources and persuade others for technical support (World Health Organization).
In the Americas where dengue is endemic, Brazil, Mexico, and Colombia are the most active countries in the management of dengue outbreaks. There is also active participation from the U.S. Centers for Disease Control and Prevention (CDC) performing the functions of technical support and control for the countries of Latin American and Caribbean regions.
Research and Innovation
Other scientists are investing in searching of new means for more precise diagnosis, treatment, and prophylaxis of this disease. New methods include the use of genetically engineered mosquitoes meant to genetically infect and hence kill certain populations of mosquitoes, which is still ongoing but has promise for larger scale use in the future.
Moreover, predictive modeling of cholera outbreaks and better targeted vector control campaigns are being aided by the use of big data analytics and AI. For example, by using these aI models based on climate data, population density and travel patterns, health authorities will be able to accurately predict dengue outbreaks in areas where it is foreseen. Building on Accomplished Results
Inspite of these advancements, there are areas where the dense surveillance llness still remains. Increasing temperatures are helping Aedes mosquitoes thrive in new and better places causing dengue outbreaks in areas previously untouched. The evolution of the virus is also another factor in how one of its contribution towards the dengue fever vaccine has yet to be fully realized.
Again, health infrastructure, especially in Africa and Southeast Asia, where the virus is endemic, is weak. Here, the health system often works under the confluence of many public health emergencies at once and therefore is unable to deal with the it’s outbreaks effectively. World Health Organization (WHO).
Conclusion.
The worldwide war on dengue is multifaceted in nature and requires collaboration among countries, scientific technologies and community engagement. Even though remarkable achievements have been attained as regarding vector control and vaccines, the increasing number of cases makes it apparent that there is need for stronger efforts and more funds. With such limitations, the struggle against it would never cease. The increase in surveillance, incorporation of novel technologies as well strengthening the health systems of the countries would help in saving the burden of Dengue and subsequently the more billion people who are at risk.
Dengue fever is no doubt a geographical disease problem, but it is no longer as simple, and we can begin to address it by putting the steps in place to do so. There are many factors including environmental, social, and biological ones causing the movement of the disease that calls for multi-sector coordination across the globe. More effective ways of managing control of the vectors, improving people’s awareness and literacy, and assisting in the development of vaccines are some of the best ways that can be taken to reduce the menace of this vaccine preventable yet fatal disease intertwined by other factors.
About The Author
